Previous Close | N/A |
Open | N/A |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | N/A - N/A |
52 Week Range | 60.00 - 60.00 |
Volume | |
Avg. Volume | 3,622 |
Market Cap | 57.903B |
Beta (5Y Monthly) | 1.61 |
PE Ratio (TTM) | 6.09 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BNP.SW
Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.
(Bloomberg) -- China set its annual growth target at around 5%, an ambitious goal that will put pressure on the nation’s top leaders to unleash more stimulus as they try to lift confidence in an economy hampered by a property slump and entrenched deflation.Most Read from BloombergAmerica Blew Almost $2 Trillion. Make It Stop.Supreme Court Rules Trump Can Appear on Presidential BallotsWall Street’s DEI Retreat Has Officially BegunApple’s iPhone Woes in China Deepen With a 24% Sales PlungeAMD Hits
More banks are backing Nasdaq Private Market, a trading platform for shares in companies that haven't yet gone public. UBS, Wells Fargo and BNP Paribas are among the new investors in Nasdaq Private Market, the venture said as it announced the closing of a $62.